Search Results 371-380 of 17095 for Anabolic

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part ...

  3. Prostate cancer - Doctors and departments - Mayo Clinic

    Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.

  4. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  5. Antihemophilic factor (recombinant) porcine sequence (intravenous route) - Side effects & dosage - Mayo Clinic

    Antihemophilic factor (AHF) recombinant porcine sequence injection is used to treat serious bleeding episodes in patients with acquired hemophilia A. The ...

  6. Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma - Mayo Clinic

    About this study. The purpose of this study is to determine how polyamine depletion impacts extracellular intratumoral guanidinoacetate abundance.

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL - Mayo Clinic

    The purpose of this study is to determine the effectiveness of MB-CART2019.1 cells administered following a conditioning lymphodepletion regimen in diffuse ...

  10. Study of LY2784544 Testing Alternative Dosing in Participants with Myeloproliferative Neoplasms - Mayo Clinic

    The purpose of this study is to determine a dose of LY2784544 that may be safely administered to participants with myeloproliferative neoplasms. Participation ...